Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome

Official record

Identifier

NCT07736079

Recruiting locations

Locations are not included in the offline baseline for this record. Open the official record to see the current site list.

Interventions studied

Not provided in the official record

Lead sponsor

GÜLDEN ANATACA

Target enrolment

60 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Not yet recruiting

First posted

Jul 30, 2026

Last updated on the registry

Jul 30, 2026

Age

18 Years – 45 Years

Sex

FEMALE

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Female participants aged 18-45 years
* Diagnosis of PCOS according to Rotterdam criteria
* BMI \<30 kg/m²
* No PCOS treatment during the previous 6 months
* Not pregnant or breastfeeding
* No active infection
* No rheumatologic or inflammatory disease
* No chronic systemic disease
* Written informed consent

Exclusion Criteria:

* Age \<18 years or \>45 years
* Pregnancy or breastfeeding
* PCOS treatment within the previous 6 months
* Active infection
* Rheumatologic or inflammatory disease
* Hypertension
* Diabetes mellitus
* Chronic kidney disease
* Refusal to participate

Indexed under

Ovarian Cancer